Problem Solvers
This company helps individuals/employers manage healthcare costs while improving access to care
Excellus/Univera
Adults 50+ with an elevated risk for cancer and/or those who are proactive about their healthcare
Grail
TG combats this competitor by focusing on an overall faster infusion process (1 hour vs 2-4)
Ocrevus
Patients prescribed Xifaxan for IBS-D often face this financial and insurance-related roadblock before starting treatment, including prior authorization requirements and high copays
Access and affordability
This acronym refers to the section of a pharmaceutical advertisement that contains critical information, including risks, warnings, and side effects required for regulatory compliance
ISI (Important Safety Information)
This biotech company developed a treatment targeting MASH, a serious liver disease with only limited approved therapies for years.
Madrigal
Adults with GERD and other esophagus/reflux related conditions
Phantom
This antifungal medication is considered one of the biggest competitors to Jublia in treating toenail fungus due to its strong efficacy and low-cost generic availability
Lamisil
Because many patients experience few noticeable symptoms in the early stages, this major roadblock often prevents people with MASH from receiving timely diagnosis and treatment.
Underdiagnosis
This acronym refers to the unique 10-digit identification number assigned to healthcare providers in the United States for billing and administrative purposes.
NPI (National Provider Identifier)
This member-focused financial institution helps people with everyday banking, loans and financial wellness instead of serving shareholders.
ESL
A young but still 21+ audience with a "grab and go" mindset
Geloso
This colorful ready-to-drink cocktail brand is considered a major competitor to Clubtails Crushers and is famous for its round plastic packaging
Buzzballs
Patients with MS often face this insurance-related roadblock before starting specialty therapies like Briumvi or Ocrevus, requiring doctors to obtain approval before treatment can begin.
Prior Authorization
This acronym refers to a type of leader — a respected physician or expert frequently used in pharma education and speaker programs
KOL (Key Opinion Leader)
This pharmaceutical company specializes in treatments for gastrointestinal diseases and digestive health conditions.
Salix
Industrial manufacturers, agricultural businesses and farmers
BASF
This blockbuster purple pill is considered one of Voquezna’s biggest competitors in the acid reflux market and belongs to the proton pump inhibitor class
Nexium
Because this multi-cancer early detection blood test is not always broadly covered by insurance, many eligible patients face this major financial roadblock before screening
Out of Pocket Cost
This acronym applies to the fast-growing alcohol category that includes canned cocktails like Clubtails Crushers
RTD (ready to drink)
This prescription acne treatment helps patients manage moderate to severe acne with a single topical product.
Cabtreo
Oncologists and/or those with RAS-driven cancers
RevMed
This pharmaceutical company was one of Madrigal’s most closely watched rivals in the race to develop treatments for NASH, now known as MASH
Intercept Pharmaceuticals
Before patients can receive many targeted therapies from Revolution Medicines, they often must overcome this precision oncology roadblock to confirm the presence of a KRAS or RAS mutation
Biomarker testing
This acronym refers to a medication’s boxed FDA warning highlighting serious or life-threatening risks
BBW (Black Box Warning)